The Association of Fenofibrate and The Risk of Retinopathy in Type 2 Diabetes

ASIA unversity > 資訊學院 > 生物資訊與醫學工程學系 > 博碩士論文 > Item 310904400/12786

請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/12786

題名:	The Association of Fenofibrate and The Risk of Retinopathy in Type 2 Diabetes
作者:	Fitri, Sulidar
貢獻者:	Department of Biomedical informatics Yu - Ching, Chen
關鍵詞:	Retinopathy;Type II Diabetes;National Health Insurance Database
日期:	2012
上傳時間:	2012-11-18 09:33:41 (UTC+0)
出版者:	Asia University
摘要:	Retinopathy is the most common complication in type 2 diabetes. Many people usually will get diabetic retinopathy when they have diabetic type 2. In Taiwan the incidence of type 2 diabetes is high, so the retinopathy prone to happen in these persons and finally might lead to blindness in the productive age. Fenofibrate is a drug for lipid control by lowering the lipid. In this research, based on the data from National Health Insurance Research Database, I study the association of using fenofibrate and the risk of retinopathy in type 2 diabetes. The results are significant because 95%CI does not include 1 and the HR is less than one, so the risk of retinopathy is low. From adjusted variable of gender (HR=0.82; 95%CI= 0.71-0.95), age (HR=0.81; 95%CI= 0.70-0.94), sex and age (HR=0.81; 95%CI= 0.70-0.94) and for not adjusted variable it obtained (HR=0.82; 95%CI= 0.71-0.95).
顯示於類別:	[生物資訊與醫學工程學系 ] 博碩士論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	607	檢視/開啟

在ASIAIR中所有的資料項目都受到原著作權保護.